Merit Medical Systems, Inc. (MMSI)
Why Merit Medical (MMSI) is Poised to Beat Earnings Estimates Again
Merit Medical (MMSI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Merit Medical Stock Gains 24.7% Year to Date: What's Behind the Rally?
MMSI shows strong growth momentum with a robust product portfolio and recent acquisitions, positioning itself well in competitive healthcare markets.
Here's Why You Should Retain Merit Medical Stock in Your Portfolio
Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
MMSI Stock Likely to Gain From Cook Medical's Product Portfolio Buyout
Merit Medical expects to solidify its foothold in the underpenetrated global lead management market via the latest asset acquisition.
Merit Medical Stock Falls Despite Positive WRAPSODY Trial Results
MMSI announces 6-month results from its WRAPSODY WAVE trial, showing superior efficacy in extending AV fistula patency for dialysis patients.
Merit Medical Gains 26.4% Year to Date: What's Driving the Stock?
MMSI's shares gain on the back of strength in its Cardiovascular segment and a robust product portfolio.
Merit Medical Systems, Inc. (MMSI) Q2 2024 Earnings Call Transcript
Merit Medical Systems, Inc. (NASDAQ:MMSI ) Q2 2024 Results Conference Call August 1, 2024 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman, and Chief Executive Officer Brian Lloyd - Chief Legal Officer and Corporate Secretary Joe Wright - President Raul Parra - Chief Financial Officer Conference Call Participants Jason Bednar - Piper Sandler Mike Matson - Needham Larry Biegelsen - Wells Fargo Steve Lichtman - Oppenheimer David Rescott - Baird Jayson Bedford - Raymond James Craig Bijou - Bank of America Securities John Young - Canaccord Jim Sidoti - Sidoti & Company Operator Ladies and gentlemen, thank you for standing by. Welcome to the Merit Medical Systems Second Quarter 2024 Earnings Conference Call.
Merit Medical (MMSI) Q2 Earnings & Revenues Beat, '24 View Up
Merit Medical's (MMSI) second-quarter results reflect growth in earnings and revenues. Operating margin expands.
Merit Medical (MMSI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Merit Medical (MMSI) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Merit Medical (MMSI) Q2 Earnings and Revenues Beat Estimates
Merit Medical (MMSI) came out with quarterly earnings of $0.92 per share, beating the Zacks Consensus Estimate of $0.88 per share. This compares to earnings of $0.81 per share a year ago.
Merit Medical (MMSI) Inks Deal to Boost Endoscopy Portfolio
Merit Medical's (MMSI) latest asset acquisition is likely to expand its endoscopy portfolio with a minimally-invasive solution for GERD patients, thereby improving patient outcomes.
Merit Medical (MMSI) Hits 52-Week High: What's Aiding It?
Investors are optimistic about Merit Medical's (MMSI) strong product portfolio.
